Physiological, Subjective and Performance Effects of Pseudoephedrine and Phenylpropanolamine During Endurance Running Exercise

Abstract

The aim of the study was to assess the effect of maximal therapeutic dosing of sympathomimetic amines found in over-the-counter (OTC) decongestant preparations on endurance running. Following familiarisation and a graded exercise test to determine maximal oxygen uptake (V˙O₂max), trained male runners (n = 8) completed four exercise sessions each separated by a minimum of one week. Each session was comprised of 20 min of sub-maximal treadmill running (70 % V˙O₂max) followed by a 5000-m time trial on the treadmill under drug, placebo or control conditions. Drugs were administered in their commercial format over the 36-hour period prior to testing in the manufacturer's recommended maximal doses (i. e. 25 mg of phenylpropanolamine and 60 mg of pseudoephedrine four times daily). During sub-maximal endurance running no statistical differences were observed in heart rate, V˙O₂, minute ventilation, respiratory exchange ratio, blood lactate, glucose or non-esterified fatty acids (NEFA) or ratings of perceived exertion with respect to the treatment administered. Similarly there were no statistical differences according to the condition during the 5000-m running time trial, in terms of heart rate, ratings of perceived exertion, time of completion and pre and post exercise blood lactate, glucose or NEFA. The results indicate that in maximal, multiple therapeutic doses both pseudoephedrine or phenylpropanolamine as present in common OTC decongestant formulations do not affect, nor possess any ergogenic properties with regard to, endurance running.

Key words

Sympathomimetic amines - drugs - sports performance

References

• 1 Berstein E, Diskant B M. Phenylpropanolamine: A potentially hazardous drug.  Ann Emerg Med. 1982;  11 311-315
• 2 Borg G V. Psychophysical bases of perceived exertion.  Med Sci Sports Exerc. 1982;  14 377-387
• 3 Bright T P, Sandage B W, Fletcher H P. Selected cardiac and metabolic responses to pseudoephedrine with exercise.  J Clin Pharmacol. 1981;  21 488-492
• 4 British Association of Sport and Exercise Sciences .Position statement on the physiological assessment of the elite competitor. 1997
• 5 Bye C, Dewsbury D, Peck A W. Effects on the human central nervous system of two isomers of ephedrine and triprolidine and their interaction.  Br J Clin Pharmac. 1974;  1 71-78
• 6 Chester N J. The use of exogenous sympathomimetic amines in sport and exercise.  PhD Thesis. Liverpool; John Moores University 2000
• 7 Clemons J M, Crosby S L. Cardiopulmonary and subjective effects of a 60 mg dose of pseudoephedrine on graded treadmill exercise.  J Sports Med Phys Fit. 1993;  33 405-412
• 8 Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed. New Jersey; Lawrence Erlbaum 1988
• 9 de Meersman R, Getty D, Schaefer D C. Sympathomimetics and exercise enhancement: all in the mind?.  Pharmacol Biochem Behav. 1987;  28 361-365
• 10 Doyle J A, Martinez A L. Reliability of a protocol for testing endurance performance in runners and cyclists.  Res Quart Exerc Sport. 1998;  69 304-307
• 11 Gibson G J, Warrell D A. Hypertensive crisis and phenylpropanolamine.  Lancet. 1972;  2 492
• 12 Gillies H, Derman W E, Noakes T D, Smith P, Evans A, Gabriels G. Pseudoephedrine is without ergogenic effects during prolonged exercise.  J Appl Physiol. 1996;  81 2611-2617
• 13 Hickey M S, Costill D L, McConell G K, Widrick J J, Tanaka H. Day to day variation in time trial cycling performance.  Int J Sports Med. 1992;  13 467-470
• 14 Johnson D A, Etter H S, Reeves D M. Stroke and phenylpropanolamine use.  Lancet. 1983;  ii: 970
• 15 Meeuwisse W H, McKenzie D C, Hopkins S R, Road J D. The effect of salbutamol on performance in elite nonasthmatic athletes.  Med Sci Sports Exerc. 1992;  24 1161-1166
• 16 Norvenius G, Widerlov E, Lönnerhölm G. Phenylpropanolamine and mental disturbance.  Lancet. 1979;  2 1367-1368
• 17 Palmer G S, Dennis SC, Noakes T D, Hawley J A. Assessment of the reproducibility of performance testing on an air-braked cycle ergometer.  Int J Sports Med. 1996;  17 293-298
• 18 Schabort E J, Hawley J A, Hopkins W G, Mujika I, Noakes T D. A new reliable laboratory test of endurance performance of road cyclists.  Med Sci Sports Exerc. 1998;  30 1744-1750
• 19 Schabort E J, Hopkins W G, Hawley J A. Reproducibility of self-paced treadmill performance of trained endurance runners.  Int J Sports Med. 1998;  19 48-51
• 20 Schwenk T L. Psychoactive drugs and athletic performance.  Physician Sportsmed. 1997;  25 32-46
• 21 Sidney K H, Lefcoe N M. The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercise in man.  Med Sci Sports. 1977;  9 95-99
• 22 Swain R A, Harsha D M, Baenziger J, Saywell R M. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?.  Clin J Sport Med. 1997;  7 168-173
• 23 Wadler G I, Hainline B. Drugs and the Athlete. Philadelphia; F.A. Davis Company 1989